Please use this identifier to cite or link to this item:
|Title:||Assessment and management of newly diagnosed classical Hodgkin lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.||Austin Authors:||Cochrane, Tara;Campbell, Belinda A;Gangatharan, Shane A;Latimer, Maya;Khor, Richard ;Christie, David R H;Gilbertson, Michael;Ratnasingam, Sumita;Palfreyman, Emma;Lee, Hui-Peng;Trotman, Judith;Hertzberg, Mark;Dickinson, Michael||Affiliation:||Monash Health, Melbourne, Victoria, Australia..
Bond University, Gold Coast, Queensland, Australia..
Genesiscare, Gold Coast, Queensland, Australia..
ACT Pathology and Canberra Hospital, Canberra, Australian Capital Territory, Australia..
University of Western Australia, Perth, Western Australia, Australia..
Fiona Stanley Hospital, Perth, Western Australia, Australia..
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia..
Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia..
University of NSW, Sydney, New South Wales, Australia..
Department of Haematology, Prince of Wales Hospital, Sydney, New South Wales, Australia..
University of Sydney, Sydney, New South Wales, Australia..
Concord Repatriation General Hospital, Sydney, New South Wales, Australia..
Flinders Medical Centre, Adelaide, South Australia, Australia..
Royal Darwin Hospital, Darwin, Northern Territory, Australia..
Andrew Love Cancer Centre, University Hospital Geelong, Geelong, Victoria, Australia..
Department of Haematology and Oncology, Western Health, Melbourne, Victoria, Australia..
School of Clinical Sciences, Monash University, Melbourne, Victoria, Australia..
Department of Clinical Pathology, University of Melbourne, Parkville, Victoria, Australia..
Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia..
School of Medicine, Griffiths University, Gold Coast, Queensland, Australia..
Department of Haematology, Gold Coast University Hospital, Gold Coast, Queensland, Australia..
|Issue Date:||Dec-2021||metadata.dc.date:||2021||Publication information:||Internal medicine journal 2021; 51(12): 2119-2128||Abstract:||The management of Hodgkin lymphoma (HL) has undergone significant changes in recent years. Due to the predilection of HL to affect younger patients, balancing cure and treatment-related morbidity is a constant source of concern for physicians and patients alike. Positron emission tomography adapted therapy has been developed for both early and advanced stage HL to try and improve the outcome of treatment, while minimising toxicities. The aim of this review is to digest the plethora of studies recently conducted and provide some clear, evidence-based practice statements to simplify the management of HL.||URI:||https://ahro.austin.org.au/austinjspui/handle/1/29080||DOI:||10.1111/imj.15503||ORCID:||https://orcid.org/0000-0002-2668-1399
|Journal:||Internal medicine journal||PubMed URL:||34505342||PubMed URL:||https://pubmed.ncbi.nlm.nih.gov/34505342/||Type:||Journal Article||Subjects:||HL
|Appears in Collections:||Journal articles|
Show full item record
checked on Jun 6, 2023
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.